SOUN Stock Cash Flow Statements

SoundHound Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

SoundHound Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31

cash flows used in operating activities:
net income	-74,724,000	129,932,000	-258,599,000	-21,751,000	-37,322,000	-33,009,000	-18,003,000	-22,633,000	-21,932,000	-26,369,000	-30,680,000	-28,922,000	-55,385,550	-385,450	-981,884	-345,648	-154,573	-84,033
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	7,774,000	7,755,000	7,939,000	5,365,000	1,280,000	1,470,000	372,000	530,000	703,000	708,000	840,000	928,000
stock-based compensation	23,810,000	17,440,000	9,853,000	9,060,000	7,253,000	6,979,000	7,292,000	6,692,000	5,698,000	8,249,000	9,292,000	9,173,000
amortization of debt issuance cost			35,000	62,000	293,000	1,231,000				16,000		52,000
loss on disposal of property and equipment	11,000	31,000
non-cash lease amortization	724,000	664,000	395,000	773,000	702,000	743,000				894,000	1,021,000	623,000
foreign currency gain/income from remeasurement	-711,000	-160,000	73,000	-27,000	-15,000	-55,000
change in fair value of contingent acquisition liabilities	31,359,000	-176,100,000	220,946,000	-1,356,000	-1,082,000	4,162,000
change in fair value of derivative	-890,000	-1,289,000
loss on early extinguishment of debt			42,000	0
deferred income taxes		-1,000	-689,000	-11,126,000	-87,000	-281,000
other	1,094,000	903,000	-1,213,000	1,524,000	-936,000	45,000
changes in operating assets and liabilities:
accounts receivable	36,000	2,347,000	-9,017,000	-1,458,000	1,459,000	-1,248,000	-665,000	156,000	-872,000	754,000	-625,000	-1,774,000
other current assets	-2,457,000	-239,000	-82,000	-1,623,000	-893,000	-533,000	-205,000	18,000	-424,000	-210,000	297,000	12,000
contract assets	-12,130,000	5,816,000	-286,000	-4,751,000	-3,206,000	939,000	-9,591,000	-7,907,000	-2,206,000	126,000	-2,482,000
other non-current assets	-665,000	-1,181,000	1,002,000	-356,000	-935,000	93,000	-19,000	62,000	609,000	19,000
accounts payable	3,416,000	1,151,000	-8,459,000	-1,118,000	1,036,000	905,000	-527,000	268,000	-647,000	-256,000	-96,000	-1,448,000
accrued liabilities	2,193,000	-8,403,000	3,904,000	-1,433,000	48,000	-673,000	2,360,000	-3,139,000	739,000	4,306,000	-1,324,000	1,332,000	-147,203	255,203
other current liabilities	-1,900,000	-581,000	-973,000
operating lease liabilities	-523,000	-836,000	-602,000	-892,000	-832,000	-888,000	-885,000	-862,000	-947,000	-963,000	-827,000	-827,000
deferred revenue	-4,558,000	3,667,000	2,807,000	-6,470,000	-917,000	-1,606,000	1,397,000	-907,000	-2,022,000	-2,603,000	-831,000	-1,453,000
other non-current liabilities	3,643,000	-101,000	-199,000	-69,000	75,000	-222,000		2,089,000	-291,000	-1,000
net cash from operating activities	-24,497,000	-19,185,000	-33,123,000	-35,315,000	-18,492,000	-21,948,000	-13,870,000	-20,744,000	-19,184,000	-14,467,000	-20,414,000	-26,838,000	-46,549,834	-217,166	-864,358	-471,001	-296,147	-185,958
capex	-192,000	-162,000	-80,000	-225,000	-236,000	-99,000	-58,000	-41,000	-278,000	-15,000	-141,000	-206,000	0	0	0	0	0	0
free cash flows	-24,689,000	-19,347,000	-33,203,000	-35,540,000	-18,728,000	-22,047,000	-13,928,000	-20,785,000	-19,462,000	-14,482,000	-20,555,000	-27,044,000	-46,549,834	-217,166	-864,358	-471,001	-296,147	-185,958
cash flows used in investing activities:
purchases of property and equipment	-192,000	-162,000	-80,000	-225,000	-236,000	-99,000	-58,000	-41,000	-278,000	-15,000	-141,000	-206,000
payment related to acquisition, net of cash acquired
net cash from investing activities	-192,000	-162,000	-80,000	-7,504,000	-1,000,000	-3,788,000	-58,000	-41,000	-278,000	-15,000	-141,000	-206,000			-133,000,000	-133,000,000	-133,000,000	-133,000,000
cash flows from financing activities:
proceeds from sales of class a common stock under the sales agreement, equity distribution agreement, and second equity distribution agreement
proceeds from exercise of stock options and employee stock purchase plan	2,100,000	666,000	18,621,000	436,000
proceeds from warrants exercised	0	13,000
payment of financing costs associated with the sales agreement, equity distribution agreement, and second equity distribution agreement
payment to settle contingent holdback liabilities from synq3 acquisition
payments on notes payable									-30,909,000	-4,120,000	-4,095,000	-4,034,000
payments on finance leases	-8,000	-21,000	-36,000	-31,000	-30,000	-28,000	-43,000	-42,000	-35,000	-39,000	-57,000	-230,000
net cash from financing activities	9,596,000	67,010,000	95,461,000	-21,585,000	-5,668,000	142,698,000	13,062,000	1,167,000	102,440,000	51,568,000	-3,612,000	-4,554,000			134,099,653	134,099,653	134,099,653	134,149,653
effects of exchange rate changes on cash	-116,000	-94,000	241,000	-146,000	27,000	103,000
net change in cash, cash equivalents, and restricted cash equivalents	-15,209,000	47,569,000	62,499,000	-64,550,000	-25,133,000	117,065,000	-886,000	-19,618,000	82,978,000	37,086,000	-24,167,000
cash, cash equivalents, and restricted cash equivalents, beginning of period	0	198,916,000		0	0	109,035,000		0	0	9,475,000		0
cash, cash equivalents, and restricted cash equivalents, end of period	-15,209,000	246,485,000		-64,550,000	-25,133,000	226,100,000		-19,618,000	82,978,000	46,561,000		-31,598,000
proceeds from sales of class a common stock under the sales agreement and second equity distribution agreement		67,707,000
payment of financing costs associated with the sales agreement and second equity distribution agreement		-1,355,000
cash flows from operating activities:
loss on change in fair value of eloc program							0
change in fair value of derivative and warrant liability											0	0
prepaid expenses							1,435,000	214,000	-922,000	863,000	1,260,000	911,000	-3,428,500	19,500	-98,066	-134,478	-147,007	-165,713
cash flows from investing activities:
payment related to acquisitions, net of cash acquired			0	-7,279,000
proceeds from the issuance of series a preferred stock, net of issuance costs									0	24,942,000
proceeds from sales of class a common stock under the eloc program, net of issuance costs
proceeds from sales of class a common stock under the sales agreement, equity distribution agreement and execute equity distribution agreement
payment of financing costs associated with the sales agreement, equity distribution agreement and execute equity distribution agreement
proceeds from the issuance of debt, net of issuance costs
proceeds from the issuance of common stock							532,000	660,000
proceeds from business combination and pipe, net of transaction costs											0	-1,006,000
payment to settle contingent holdback liabilities from synq3 and other acquisitions
cash, cash equivalents, and restricted cash equivalents, beginning of year
cash, cash equivalents, and restricted cash equivalents, end of year
proceeds from sales of class a common stock under the sales agreement and equity distribution agreement				49,632,000
payment of financing costs associated with the sales agreement and equity distribution agreement				-1,543,000
payments on term loan and amelia debt
proceeds from the issuance of long-term debt, net of issuance costs								0
acquisition of synq3, net of cash acquired						-3,689,000
proceeds from sales of class a common stock under the sales agreement						137,274,000
proceeds from the issuance of class a common stock upon exercise of options						8,887,000
payment of financing costs associated with eloc program
payment of financing costs associated with the sales agreement						-3,435,000
amortization of debt issuance costs
loss on debt extinguishment							0	0
other liabilities												795,000
proceeds from sales of common stock under the eloc program, net of issuance cost
proceeds from sales of common stock under the sales agreement
proceeds from issuance of debt, net of issuance costs
reconciliation to amounts on the consolidated balance sheets:
cash and cash equivalents										46,331,000	-24,167,000	-31,598,000
current portion of restricted cash equivalents
non-current portion of restricted cash equivalents										230,000	0	0
total cash, cash equivalents, and restricted cash equivalents shown in the consolidated statements of cash flows
non-cash interest expense								1,925,000
non-cash lease expense								669,000
other non-cash losses								180,000
proceeds from the issuance of series a preferred stock
proceeds from sales of common stock under the eloc program, net of transaction costs
payments on long-term debt
supplemental disclosures of cash flow information:
cash paid for interest								3,601,000	3,270,000	1,074,000	2,062,000
cash paid for income taxes								547,000	548,000	550,000	257,000
noncash investing and financing activities:
non-cash debt discount								-179,000
conversion of series a preferred stock to common stock
issuance of common stock to settle commitment shares related to the eloc program
conversion of convertible note into common stock pursuant to business combination											0	0
conversion of redeemable convertible preferred stock to common stock pursuant to business combination											0	0
operating lease liabilities arising from obtaining right-of-use assets											0	0
proceeds from sales of common stock under the eloc program, net of issuance costs									42,545,000	28,360,000
accrued and unpaid debt issuance costs
deferred offering costs reclassified to additional paid-in capital									479,000	323,000
unpaid deferred offering costs associated with the business combination
proceeds from the issuance of common stock upon exercise of options										2,425,000	540,000	716,000
reconciliation to amounts on the condensed consolidated balance sheets:
total cash, cash equivalents, and restricted cash equivalents shown in the condensed consolidated statements of cash flows										46,561,000		-31,598,000
unpaid issuance costs in connection with the eloc program										437,000
proceeds from issuance of convertible notes, net of issuance costs
proceeds from note payable, net of issuance costs
operating lease liabilities and right-of-use assets through adoption of asc 842
property and equipment acquired under finance leases or debt
debt discount through issuance of common stock warrants
issues of series c redeemable convertible preferred stock for exercise of warrants
other assets												-64,000
proceeds from issuance of convertible notes, net of issuance cost
proceeds from note payable, net of issuance cost
noncash investing and financing activities
net increase in cash, cash equivalents, and restricted cash equivalents
cash paid for:
interest
income taxes
adjustments to reconcile net income to net cash from operating activities
unrealized (gain) loss on change in fair value of warrants														-92,746
interest earned on marketable securities held in trust account														-11,857	-10,583	-7,230	-3,878	-525
changes in current assets and current liabilities:
due to related party														-1,816	1,100	-716	9,284	6,381
investment held in trust account															-133,000,000	-133,000,000	-133,000,000	-133,000,000
proceeds from ipo and over-allotment															133,000,000	133,000,000	133,000,000
payment of underwriting fees															-2,660,000	-2,660,000	-2,660,000
proceeds from private placement															4,160,000	4,160,000	4,160,000	4,160,000
proceeds from issuance of promissory note to related party															125,000	125,000	125,000	125,000
payment to promissory note to related party															-125,000	-125,000	-125,000	-125,000
proceeds from issuance of common stock to initial stockholders															25,000	25,000	25,000	25,000
payment of deferred offering costs															-425,347	-425,347	-425,347	-375,347
net change in cash														-217,166	235,295	628,652	803,506	963,695
cash, beginning of the period														235,295
cash, end of the period														18,129		628,652	803,506	963,695
supplemental disclosure of cash flow information
initial value of common stock subject to possible redemption															124,413,913	124,413,913	124,413,913	115,841,700
reclassification of offering costs related to public shares															-4,779,936	-2,886,166	-2,886,166
accretion of common stock to redemption value														11,857	13,366,023
forfeiture of founder shares															13	13	13	13
initial classification of warrant liability															270,307	270,307	270,307	270,307
deferred offering costs included in accrued expenses
●
unrealized gain on change in fair value of warrants															-22,793	-108,948	-73,891
accrued expenses															247,868
cash, beginning of the year
cash, end of the year															235,295
audited balance sheet at march 15, 2021
warrant liabilities
total liabilities															591,387			591,387
common stock subject to possible redemption															116,095,120	116,095,120	116,095,120	116,095,120
common stock															465	465	465	465
additional paid-in capital															5,004,068	5,004,068	5,004,068
total stockholder’s equity															5,000,003
unaudited balance sheet at march 31, 2021
unaudited statement of operations for the three months ended march 31, 2021
basic and diluted weighted-average shares outstanding, common stock subject to redemption															2,059,408	2,059,408	2,059,408
basic and diluted weighted-average shares outstanding, common stock															3,856,614	3,856,614	3,856,614
basic and diluted net income per share, common stock subject to redemption															0	0	0
basic and diluted net income per share, common stock not subject to redemption															-0.02	-0.02	-0.02
accrued offering costs and expenses																126,019	73,918	54,815
subsequent measurement of common stock subject to redemption																11,472,253	11,472,253
balance sheet at march 15, 2021
balance sheet at march 31, 2021
statement of operations for the three months ended march 31, 2021
statement of cash flows for the three months ended march 31, 2021
change in value of common stock subject to possible redemption																12,902,890	12,902,890	12,902,890
unrealized loss on change in fair value of warrants																		3,117
proceeds from ipo and over-allotment, net of underwriters’ fees																		130,340,000
deferred offering costs included in accrued offering costs and expenses																		50,000
as of march 15, 2021
balance sheet
additional paid in capital																		5,004,068

We provide you with 20 years of cash flow statements for SoundHound stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of SoundHound stock. Explore the full financial landscape of SoundHound stock with our expertly curated income statements.

The information provided in this report about SoundHound stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.